ankylosing spondylitis patients, as well as the effects of TNFi therapy and the host's genotype upon 2 microbiome composition. 3 4
restored the perturbed microbiome observed in untreated AS cases to that of healthy controls, including 48 several important bacterial species that have been previously associated with AS and other related 49 diseases. Enrichment of bacterial peptides homologous to HLA-B27-presented epitopes was observed in 50 the stools of AS patients, suggesting that either HLA-B27 fails to clear these or that they are involved in 51 driving HLA-B27-associated immune reactions. TNFi therapy of AS patients was also associated with a 52 reduction of potentially arthritogenic bacterial peptides, relative to untreated patients. An AS-associated 53 SNP in RUNX3 significantly influenced the microbiome in two independent cohorts, highlighting a host 54 genotype (other than HLA-B27) potentially influencing AS via the microbiome. These findings emphasise 55 the key role that the gut microbiome plays in driving the pathogenesis of AS. 56
INTRODUCTION 57
Ankylosing spondylitis (AS) is a chronic inflammatory disease affecting primarily the spine and pelvis, 58 causing pain and initially reversible stiffness, and ultimately leading to joint ankylosis due to ectopic 59 bone formation. In a subset of patients, peripheral joints and extra articular tissues including the eye, 60 gut and skin are also involved. Its prevalence in Asian and European descent populations ranges from 61 0.09% to 0.55% 1,2 , whereas the disease is rare in most of Africa, likely due to the low frequency of the 62 main susceptibility gene, HLA-B27 3 . There is a significant unmet therapeutic need in AS, with limited 63 evidence that current therapies prevent spinal ankylosis, no oral treatments which suppress disease 64 activity other than corticosteroids, and no treatments which have been demonstrated to induce 65 remission or prevent the disease. 66 67 AS has been shown in both twin and unrelated case/control studies to be highly heritable (twins >90% 68 heritability 4, 5 , unrelated case/control common variant heritability 69% 69 (http://www.nealelab.is/blog/2017/9/15/heritability-of-2000-traits-and-disorders-in-the-uk-biobank)). 70
Over past decade, at least 116 susceptibility genes have been identified, contributing 29% of the overall 71 risk of the disease 6 . There is substantial evidence suggesting that the interaction between host genetics 72 and gut microbiome is a key driver of the pathogenesis of AS. The high disease heritability indicates that 73 the environmental factors involved in the disease are likely to be ubiquitous. Reactive arthritis is a 74 spondyloarthritis sharing many clinical and genetic features with AS, and is known to be caused by 75 bacterial infections of the gut or urinary tract; a subset of reactive arthritis patients go on to develop AS. 76 About 60% AS patients suffered from subclinical bowel inflammation and 10% of them can be diagnosed 77 as inflammatory bowel disease (IBD) 7 . There is considerable overlap in the overall heritability of AS and 78 IBD 8 , the two diseases are often co-familial 9 , and many shared genetic associations have been 79 identified 10 . A bioinformatic study showed that AS susceptibility genes specifically enriched in gut cells 80 4 are also enriched in 'response to bacterium' GO term pathway, and that AS-associated genetic loci are 81 found disproportionately to lie within epigenetic marks of gene activity in gut tissue and cells 11 . 82
Germ-free HLA-B27-transgenic rats and SKG mice are disease-free 12, 13 . Studies using sequencing-83 based bacterial profiling of terminal ileal biopsies showed that AS patients have a distinct microbiome 14 , 84 a finding that has subsequently been reproduced studying stool samples in AS patients and patients with 85 spondyloarthritis (SpA), a broader clinical classification 15, 16 . There has also been suggestive evidence 86 reported that the gut microbiome is associated with differences in AS disease activity 17 . In addition, one 87 study compared SpA patients' stool samples before and three months after TNF-inhibitor (TNFi) 88 treatment onset 18 . Although modest changes were found in microbiome alpha-diversity measures after 89
TNFi treatment, no changes in specific bacterial taxa were observed. This may have been related to 90 power or sampling issues, noting that 15/18 patients studied met only the ASAS axial spondyloarthritis 91 classification criteria rather than having the more specific diagnosis, AS. In summation, the above 92 evidence supports the contention that AS status is influenced by interactions between the gut 93 microbiome and the host immune system. 94
95
To date, the mechanisms involved in the interaction between the host immune system and intestinal 96 8 references where possible, and HUMAnN2 v0.11.1 33 was used for functional mapping to KEGG 154 Orthogroups (KO) and MetaCyc pathways and utilising a UniRef90 database. 155 156 For prediction of bacterial peptides homologous to previously reported HLA-B27-presented epitopes, 157 bacterial-derived sequencing reads were BLASTXed against a local, BLAST-formatted 34 , version of the 158 immune epitope database (IEDB) v3.0 (downloaded August 2016) 35, 36 . BLAST best-hits with an E-value < 159 0.1 were retained, annotated according to a published study 37 and then counted. The peptides 160 annotated as HLA-B27-presented were compared between AS patients and healthy controls using 161
Fisher's exact test. 162
163

Statistical Analysis 164
Abundance tables were arcsine square root transformed prior to analysis. Multidimensional data 165 visualisation was conducted using a sparse partial least squares discriminant analysis (sPLSDA) as 166 implemented in R as part of the MixOmics package v6.3.1 38 , at the species level using Bray-Curtis 167 distance matrices. Receiver operating characteristic curve was calculated from sPLSDA using the 168 MixOmics package v6.3.1. Controlling for covariates (such as gender, BMI, age and smoking status) 169 where appropriate, multivariate association of the bacterial species composition with metadata of 170 interest was conducted using a PERMANOVA test as part of vegan v2.4-5 39 . The alpha diversity of 171 bacterial species was calculated using the rarefy function, as implemented in vegan v2.4-5. Univariate 172 association of bacterial species and functional pathways/groups were tested for significance using 173 MaAsLin v0.0.5 40 and Wilcoxon rank-sum tests as implemented in R 41 . Only results which were 174 significant in both tests were reported in the main text. For measurement of microbial epitope richness, 175 12 autoimmune diseases 42 . TNFi therapy appeared to partially normalise the dysbiotic bacterial species 250 and KEGG Orthogroups observed in AS cases relative to healthy controls shown in Figures 1B and 1C , 251 however no statistically significant differences between treated and untreated cases were observed, 252 potentially due to sample size constraints ( Supplementary Figure 4) . 253
254
The above approach was also used to identify metabolic pathways modulated by TNFi therapy. 20 255
MetaCyc metabolic pathways were identified in total and the perturbed abundance observed in 256 untreated AS cases was restored to healthy control levels in 17 of these. In broad terms, these pathways 257 primarily related to amino acid biosynthesis (notably branched-chain and aromatic amino acid 258 biosynthesis), carbohydrate metabolism (notably starch degradation), nucleotide biosynthesis, 259 metabolite biosynthesis and cell structure. Specific details of the 20 differentially abundant MetaCyc 260 pathways are available in Supplementary Table 7 . 261 262 Linear regression was used to investigate the association of between the modulated species and 263 modulated pathways ( Supplementary Table 8 ). Except for PWY-6545: Pyrimidine biosynthesis which was 264 not associated with any individual identified species, all the pathways were significantly associated with 265 at least two of the identified species. Similarly, all the species were significantly associated with multiple 266 pathways, however the abundances of Bilophila unclassified and Klebsiella pneumonieae were inversely 267 correlated with pathway abundance. An increase in Klebsiella pneumonieae was associated with a 268 decrease in the abundance of PWY-6737: starch degradation (P = 0.014; R 2 = -0.0426). The observed 269 decrease in the starch degradation pathway for untreated AS cases is primarily attributed to a depletion 270 of Faecalibacterium prausnitzii (P = 2.38x10 -24 ; R 2 = 0.3123). Genome-wide association studies (GWAS) have identified many genetic loci which are associated with 280 AS. Emerging evidence indicates that alleles such as HLA-B27 may influence the disease through its 281 effect upon the gut microbiome 43,44 . To investigate whether additional loci may affect the gut 282 microbiome and potentially influence disease, we performed PERMANOVA analysis upon loci known to 283 be associated with AS. 284
285
Considering non-MHC loci, an association was noted for rs11249215, a SNP in the promoter of runt-286 related transcription factor 3 (RUNX3) gene known to be associated with AS 45,46 . This variant was 287 associated with a shift in the microbiome of both AS cases and healthy controls (combined P = 0.0097). 288
Furthermore, sPLSDA revealed that the degree alteration appears dependent on whether the host 289 carried a heterozygous or homozygous genotype ( Figure 3A) , with the homozygous genotype resulting in 290 a more substantial shift. As further confirmation, we analysed a recently published 16S metabarcoding 291 dataset 47 of 107 healthy control subjects which were sampled from six different body sites. This analysis 292 re-confirmed discrimination of the microbiomes based on genotype (PERMANOVA; P = 0.0001) ( unable to be investigated due to high prevalence of this genotype in AS cases and low prevalence in 298 healthy controls, thus the effect of HLA-B27 was unable to be discerned from the effect of AS itself. 299
300
To highlight the key bacterial species affected by rs11249215, species associated with the heterozygous 301 (AG) and homozygous (GG) genotypes, or solely the homozygous (GG) genotype were identified ( Figure  302 3C). Several bacterial species showed differential abundance for the AG genotype, but not the GG 303 genotype, potentially due to sample size constraints (the GG genotype was present in 37 of the 188 304 genotyped subjects), and thus were excluded from further analysis. Four key species identified as 305 depleted in the AG/GG genotypes were: Lachnospiraceae bacterium 1 1 57FAA, Eubacterium 306 ventriosum, Citrobacter freundii and Citrobacter unclassified ( Supplementary Table 9 ). 307 308 Six MetaCyc metabolic pathways were found to be differentially abundant when comparing RUNX3 309 rs11249215 genotypes ( Figure 3D ). Similar to the differences found for TNFi therapy, the differential 310 pathways were primarily associated with amino acid and nucleotide biosynthesis, however notable 311 differences in polyamine biosynthesis and pyruvate fermentation (to acetate and lactate) were also 312 observed. Of interest is the polyamine biosynthesis pathway for the role of polyamines in enhancing the 313 integrity of the intestinal epithelial cell barrier, and the adenosine biosynthesis pathway for the anti-314 inflammatory and immunosuppressant effect of adenosine ( Supplementary Table 10 ) 48, 49 . 315 316 Linear regression of these species with the metabolic pathways revealed relatively marginal 317 associations, with the two Citrobacter species exhibiting no association with any metabolic pathway 318
( Supplementary Table 11 ). 16S rRNA gene metabarcoding analysis of the predominately Caucasian 319 cohort sampled from various body sites ( Figure 3B ) revealed a different set of taxa and metabolic 320 pathways potentially influenced by the RUNX3 SNP ( Supplementary Tables 12 and 13 ). The minimal 321 15 overlap with the current shotgun metagenomic study is potentially indicative of the differences between 322 the metagenomic approaches and/or differences in studied cohorts (i.e. geographic location, diet, 323 ethnicity…etc). 
Bacterial-derived HLA-B27 epitopes in AS cases and healthy controls 335
The main physiological function of HLA-B27 is to present peptides to CD8 lymphocytes, thereby driving 336 cell mediated immune reactions. Differences in the presence of HLA-B27-positive epitopes in the gut 337 microbiome in cases compared to controls, and in HLA-B27 carriers compared with HLA-B27-negative 338 subjects, would be consistent with effects of HLA-B27 to 'shape' the gut microbiome, and the 339 significance of this in regards disease pathogenesis. 340
341
To investigate the abundance of bacterial peptides homologous to HLA-B27 epitopes in AS cases and 342 healthy controls, translated nucleotide searches were performed against IEBD v3.0, annotated according 343 to a published study 37 and counted. Significant enrichment of these peptide sequences was observed in 344 AS cases, with 24 of these enriched in both the discovery and validation cohorts (Table 1) . AS cases not 345 16 only exhibited enrichment of these peptides but the overall diversity of peptides was increased, with 346 Shannon, Inverse Simpson and Chao diversity indices revealing significant differences between AS cases 347 and healthy controls ( Figure 4A ). 348
349
TNFi treatment effects were also investigated. The overall abundance and diversity of bacterial peptides 350 homologous to HLA-B27-presented epitopes was significantly different between the different treatment 351 categories ( Figure 4B ). Untreated AS cases exhibited increased abundance and diversity of peptides. For 352 patients who underwent TNFi therapy, a reduction in these potentially arthritogenic peptides was 353 observed relative to untreated cases, however their levels remained marginally higher than healthy 354 controls. 355
DISCUSSION
356
Gut dysbiosis in ankylosing spondylitis 357
This study re-confirmed the occurrence of bacterial gut dysbiosis in AS cases and identified seven 358 bacterial species which were commonly differentiated between cases and controls in both the discovery 359 and validation cohorts ( Figure 1B ). Two of these species, Bifidobacterium adolescentis and Coprococcus 360 comes, have been noted for their depletion in Crohn's Disease 51 and were also observed to be depleted 361 in AS cases in this study. An additional two species previously reported to be associated with AS, 362
Prevotella copri and Dialister invisus, were found to be differentially abundant in either the discovery or 363 validation cohorts ( Supplementary Table 2 ). In the case of Prevotella copri, previous studies have 364 demonstrated enrichment in new onset RA cases yet depletion in chronic RA cases 52 . Consistent with 365 these findings, our study found that Prevotella copri was depleted in AS cases within the non-age-366 matched cohort, for which the demographics were heavily skewed towards older AS patients with long-367 standing disease ( Supplementary Table 1 ). Previous studies in AS have shown increases in Prevotellaceae 368 14 , or specifically with this species 15 . As discussed below, Prevotella copri carriage normalised with TNFi 369 treatment. Further studies will be required to determine if Prevotella copri carriage changes with 370 disease duration, as has been reported in RA. 371 372 Carriage of Dialister species has been previously associated with disease activity in spondylarthrosis 373 patients 17 , but the carriage of Dialister invisus has been reported to be decreased in inflammatory 374 bowel disease (IBD) 53,54 . Whilst we found enrichment of Dialister invisus in AS cases in the discovery 375 cohort, this was not confirmed in the validation cohort, nor has it been reported in other AS studies. Its 376 pathogenic significance is therefore uncertain. 377
378
Of particularly interest, the notable 'peace keeping' microbe Faecalibacterium prausnitzii was also found 379 to be depleted in AS cases in the validation cohort. This bacterium has also been consistently shown to 380 be depleted in IBD 54-59 , and has been previously shown to be depleted in the disease enthesitis-related 381 arthritis, a paediatric disease-classification which includes children with ankylosing spondylitis 60 . 382
Faecalibacterium prausnitzii is known to produce butyrate and other metabolites and peptides that have 383 diverse anti-inflammatory effects including promoting T-regulatory cell differentiation 61 , influences on 384 Th17 lymphocyte activation, and promotion of gut mucosal barrier function 59,62,63 . As discussed below, 385
TNFi treatment also led to normalisation of Faecalibacterium prausnitzii carriage. These findings suggest 386 that Faecalibacterium prausnitzii plays a key anti-inflammatory role in AS, as it does in IBD. 387
388
The power of metagenome sequencing is to augment the widely observed phenomena collectively 389 referred to as "dysbiosis" beyond taxonomy-based assessment of microbiome, and provide a more 390 highly resolved and functional characterisation of the microbiome. Here, variation in several KEGG 391
Orthogroups remained consistent between the discovery and validation cohorts ( Figure 1C ). 392
Additionally, differential abundance of some MetaCyc metabolic pathways was also observed 393
( Supplementary Table 4 ), but these differences were not consistent between discovery and validation 394 cohorts; potentially highlighting the confounding influence of the host's age upon the metabolic 395 composition of the gut microbiome. Another important microbe, Prevotella copri, was observed to be enriched to levels closely matched to 427 that of healthy controls following TNFi treatment. Abundance of Prevotella copri has previously been 428 shown to be enriched in untreated new onset RA patients yet depleted in chronic RA cases, patients 429 with psoriatic arthritis and healthy controls 52 . Colonisation of SKG mice with Prevotella copri-dominated 430 microbiota from RA patients exhibited increased number of Th17 cells in the large intestine 75 . HLA-DR-431 presented peptides (T cell epitopes) from Prevotella copri were recently found to stimulate Th1 432 responses in 42% of new onset RA cases, with subgroups of RA patients demonstrating differential IgG 433 or IgA immune reactivity, providing evidence that Prevotella copri is immune-relevant in RA 434 pathogenesis 76 . Additionally, the presence of the HLA-DRB1 risk allele, which influences disease 435 severity, in RA patients was found to be inversely correlated with Prevotella copri abundance 52,77-79 . A 436 recent study of Chinese AS patients revealed enrichment of Prevotella copri, as well as Prevotella 437 melaninogenica and Prevotella sp. C561 15,80 . Contrasting these results, in the current study we observed 438 depletion of Prevotella copri in untreated AS cases, which was restored to the healthy control levels in 439
TNFi-treated patients. These seemingly conflicting reports of Prevotella copri abundance may be 440 explained by the large degree of intraspecific genetic diversity of Prevotella copri strains, with strain 441 variation adding an additional layer of complexity for predicting the function of Prevotella copri in the 442 gut. The Prevotella genus also contains members that may be beneficial, and which do not function as 443 pathobionts 77-79 , with observed enrichment in healthy individuals. Taken together, our results which 444 demonstrate a modulation of Prevotella copri abundance in TNFi-treated cases is a noteworthy 445 observation, however without a stronger grasp of the strain-level genome variation within this taxon 446 and their prevalence across our cohort, attempts to therapeutically modulate and predict the effects of 447
Prevotella copri remains a significant challenge 81 . 448
449 Klebsiella pneumoniae has also been suggested to play a significant role in AS pathogenesis 82 , although 450 this remains controversial 83 . Klebsiella pneumoniae notably produces pullulanase, a starch-debranching 451 enzyme which enables the degradation of starch into simple sugars 84 . The apparent arthritogenic 452 effects of dietary starch in AS are based on the concept that the growth of Klebsiella sp. are favoured by 453 these diets and drive AS pathogenesis 85,86 . Consequently, low starch diets have been promoted and are 454 frequently followed by patients 86 , although there is no published evidence to date as to their efficacy in 455 positively affecting AS disease course. Here, we actually observed a depletion of this microbe in 456 untreated cases relative to healthy controls, whereas TNFi-treated cases showed a restoration of this 457 bacterium. Furthermore, our metagenome sequencing data showed an inverse correlation between 458
Klebsiella pneumoniae relative abundance and the overall starch degradation metabolic pathway (P = 459 0.014; R 2 = -0.043) ( Supplementary Table 5 ). This pathway not only includes the pullulanase-mediated 460 starch de-branching reaction, but also further downstream reactions including the transport and 461 catabolism of maltodextrins. These findings do not support an association between Klebsiella 462 pneumoniae and AS pathophysiology, although the role of dietary and/or resistant starches on the gut 463 microbiota and AS warrants further investigation. 464 465 MetaCyc pathway analysis revealed depletion of the aromatic and branched-chain amino acid 466 biosynthesis pathways in untreated AS cases, which are responsible for production of four of the nine 467 essential amino acids in humans (leucine, isoleucine, valine and phenylalanine) ( Supplementary Table 7 ). 468
Vitamin B6 is an essential co-factor for branched-chain amino acid transaminase, the last step of 469 branched-chain amino acid synthesis, and was found to be depleted in RA cases, as previously 470 mentioned. Therefore, in the current study we not only observed a depletion of genes encoding the 471 branched-chain amino acid biosynthesis pathway, but also for the enzyme which synthesises an 472 important co-factor in the process. 473 22 474
Enrichment of potentially arthritogenic bacterial peptides 475
Pathogenic bacteria have long been hypothesised as an immunological triggers of AS pathogenesis. In 476 the current study, patients with AS not only demonstrated an enrichment of bacterial peptides matching 477 HLA-B27 epitopes (Table 1) , but the diversity of these peptides was greater overall ( Figure 4A ). These 478 data provide supporting evidence for the molecular mimicry hypothesis for which bacterial-derived 479 peptides may stimulate AS via cross-activation of autoreactive T-or B-cells, thus leading to 480 autoimmunity. This hypothesis does not however explain the increase in HLA-B27 epitopes amongst AS 481 cases, which could be explained by effects of non-HLA genetic factors, or AS-associated environmental 482
factors. An alternate hypothesis is that their excess carriage is caused by a deficiency in the ability of 483 HLA-B27 to effectively control their presence, consistent with evidence of increased bacterial migration 484 across the gut mucosa in AS 87 . Interestingly, the modulation of the gut microbiome caused by TNFi 485 treatment restored the elevated abundance and diversity of peptides observed in untreated cases to 486 levels which were more closely matched to healthy controls ( Figure 4B ). Further research will be 487 required to resolve these alternate hypotheses. 488 489
Effect of host genotype upon the microbiome 490
Very recently, it was demonstrated that HLA-B27 is associated with a significant shift in the microbiome 491 in healthy individuals 47 . Furthermore, in mouse models, MHC polymorphisms were demonstrated to 492 contribute to an individual's microbial composition, thus influencing health 88 . Our investigation 493 revealed an additional AS-associated SNP, rs11249215 in RUNX3 45,46 , which was also correlated with a 494 significant shift in bacterial composition ( Figure 3A) . This result was replicated in a confirmatory dataset 495 of healthy Caucasian individuals ( Figure 3B ). In addition to potential roles in autoimmune diseases, 496 variants in RUNX3 have been associated with the intestinal inflammatory disorder celiac disease 89 , and 497 RUNX3-knockout mice spontaneously develop IBD 90 . It is therefore tempting to hypothesise that the 498 role of RUNX3 in disease pathogenesis is, at least in part, caused by perturbation of the gut microbiome. 499
Interestingly, subjects homozygous for rs11249215 exhibited a significant decrease in the abundance of 500 the polyamine biosynthesis superpathway ( Figure 3D ). The intestinal tract contains high levels of 501 polyamines which are critical for cell growth and can stimulate the production of junction proteins 502 which are crucial for regulating paracellular permeability and reinforcing epithelial barrier function. 503
Shifts in host and microbial polyamine metabolism may also alter the cytokine environment and induce 504 cellular processes in both acute and chronic inflammatory settings 49 . A potential relationship between 505 RUNX3, microbial composition, intestinal polyamine levels and epithelial permeability and/or the 506 cytokine environment warrants further investigation. 507 508 24
CONCLUSION 509
In this study we confirm that AS is characterised by gut dysbiosis and identify key indicator species, 510 several of which are shared with IBD. This dysbiosis is associated with functional differences in the 511 microbiome involving known inflammation-related pathways. We demonstrate that treatment with 512 TNFi, which is highly effective in suppressing the clinical manifestations of AS, normalises the gut 513 microbiome, and its functional properties, in AS cases. We further demonstrate that the AS gut 514 microbiome is enriched for bacterial peptides that have previously been shown to be presented by HLA-515 B27, and that this enrichment is also normalised by TNFi treatment. The impact of the host's genotype 516 upon microbiome composition was also highlighted, with an AS-and IBD-associated SNP in RUNX3 517 correlating with a shift in microbiome composition. These findings are consistent with disease models in 518 which AS pathogenesis is driven by interactions between a genetically primed host immune system, and 519 the gut microbiome, and point to potential therapeutic and/or preventative approaches for the disease. Table 1 : Bacterial pep�des homologous to HLA-B27-presented epitopes which were commonly enriched in the discovery and valida�on cohorts for AS cases.
